IngredientsCommon name: Bovine heart; beef heart; desiccated bovine heart
Source: The cardiac muscle (myocardium) of Bos taurus (domestic cattle). Beef heart is both an organ meat and a muscle meat β it is technically the prepared heart of a cow. Technically a muscle, which means it has a familiar taste, texture, and flavor, heart is in fact considered offal.
Taxonomic classification: As an animal tissue rather than a botanical ingredient, bovine heart carries no botanical binomial name. It is classified as an "offal" or "variety meat" under food and regulatory frameworks. Offal, also called variety meats, is cut from beef, lamb, veal, chicken, duck, goose, turkey, mutton, and pork, and is either consumed directly as food or used in the production of other foods.
Common forms and preparations:
Freeze-drying is designed to retain more nutrients than high-heat drying, but it is not perfect. Vitamins like vitamin C and certain B-vitamins are particularly susceptible to loss during processing and storage. Research on nutrient stability during freeze-drying confirms significant variation depending on processing time, temperature, and storage conditions.
Across geography, climate, and century, every traditional culture that hunted or raised animals ate the organs. Anthropological research shows a clear pattern: when early humans made a kill, the first parts eaten were the organs, sometimes raw, often on the spot. The liver, heart, brain, and kidneys were viewed as sacred foods, energising and restorative.
Anthropological research shows that the ancients prized fresh organ meats above any other food. When times were tough, organ meats were allotted to leading chiefs, pregnant women, and children β but when times were good, they were distributed to everybody.
All traditional cultures consume some sort of animal food; the whole animal is consumed β muscle meat, organs, bones, and fat, with the organ meats and fats preferred.
Arctic and Subarctic Peoples (Inuit and related groups): The traditional Arctic Inuit are known to consume a diet of caribou muscle and organ meat as well as the skin, fat, and organs of fish and mammals from the sea.
Indigenous North Americans: Indigenous North Americans in the Canadian Rockies consumed wild moose and caribou year-round and learned that organ meats were superior to muscle meat and had medicinal properties. They also had superior knowledge when it came to the benefits of organ meats over muscle meat, and often fed muscle meat to dogs after a hunt.
Indigenous food systems broadly: Foods harvested by indigenous peoples generally included seeds, nuts, corn, beans, chile, squash, wild fruits and greens, herbs, fish and game, including the animal's meat, organs and oils.
The "like supports like" doctrine: Many traditional cultures practiced a principle sometimes described as "like supports like" β the idea that organ meats from a specific tissue supported that corresponding tissue in the body. Liver for liver health; heart for cardiovascular vitality. The peoples in ancient China, Greece, as well as in several Native American and African tribes, believed that eating a specific organ from an animal could heal that same organ in the person consuming it.
Between 1931 and 1948, Weston A. Price and his wife travelled to fourteen distinct indigenous cultures across the world. He brought portable equipment to measure dental health, took photographs, collected blood samples, and analysed the diets of these populations, compiling his findings in his 1939 book Nutrition and Physical Degeneration, regarded as one of the most comprehensive anthropological studies of traditional food systems ever conducted. Price's research showed that the traditional diets of these cultures, which were rich in nutrient-dense foods such as organ meats, seafood, and fermented foods, were associated with excellent physical and dental health. These are observational anthropological findings, not controlled clinical trials, and their interpretation remains a matter of scientific debate.
Beef heart is a best source (>50% daily value) of CoQ10, vitamin B2 (riboflavin), and vitamin B12 (cobalamin); an excellent source (20β50% daily value) of choline, copper, iron, protein, selenium, vitamin B1 (thiamin), vitamin B3 (niacin), vitamin B5 (pantothenic acid), and vitamin B7 (biotin); and a good source (10β20% daily value) of phosphorus, taurine, vitamin B6 (pyridoxine), and zinc.
Coenzyme Q10 content has been measured as 109.97 Β± 1.54 ΞΌg/g in beef heart, 33.34 Β± 1.43 ΞΌg/g in beef liver, and 23.47 Β± 1.06 ΞΌg/g in beef M. longissimus dorsi muscle. In approximate per-100 g terms, animal organ meats have the highest amounts of CoQ10 per 100 grams β a beef heart has 11.3 milligrams, and a beef liver has 3.9 milligrams.
The highest CoQ10 concentration was found in beef heart (over 100 mg/kg), where CoQ10 intake reached 100 mg/d when approximately 1 kg per day of beef heart was consumed. Although beef heart is the most abundant source of CoQ10, it is not used as a daily food in some parts of the world.
Beef heart contains both ubiquinone and ubiquinol, with a higher proportion of the latter. This sets it apart from many other dietary sources of CoQ10 β such as fruits and vegetables β which often contain only the ubiquinone form. The presence of ubiquinol in beef heart makes the CoQ10 more bioavailable because this form is easily absorbed and readily usable by the body.
Cooking affects CoQ10 content: beef meat samples β especially beef liver and beef heart β were important sources of CoQ10 because of their high content in cooked samples and digestibility; however, the lowest CoQ10 retention after cooking was found in the frying of beef heart. Cooking methods can affect CoQ10 content to varying degrees. Frying may cause greater reductions. Raw or minimally processed foods generally retain higher concentrations.
The amino acid taurine has numerous biological functions; the dipeptide carnosine is a buffer as well as an antioxidant; coenzyme Q10 is also an antioxidant present within mitochondria; and creatine along with creatine phosphate is involved with energy metabolism in muscle.
Large differences were shown for all compounds between beef cheek muscle (predominantly red fibres) and beef semitendinosus muscle (mainly white fibres), with cheek muscle containing 9.9 times as much taurine and 3.2 times as much coenzyme Q10. Heart tissue, being composed almost entirely of red (oxidative) muscle fibres, is correspondingly rich in taurine.
It is concluded that biologically, and possibly nutritionally, significant levels of taurine, carnosine, coenzyme Q10, and creatine are present in beef and lamb, but that these levels vary between muscles, between animals, and with cooking.
The human pool of L-carnitine is approximately 20 g, of which 98% are located in the cardiac and skeletal muscles, while 1.4% in the liver and kidneys, and 0.6% in the extracellular fluid. The most important dietary sources of L-carnitine include animal-origin products: beef, pork, chicken breast, fish, and lamb, as well as products such as milk, eggs, and cheeses.
Besides major components, meat is rich in bioactive components, primarily taurine, L-carnitine, choline, alpha-lipoic acid, conjugated linoleic acid, glutathione, creatine, coenzyme Q10, and bioactive peptides.
Bovine heart is an excellent source of B vitamins, particularly B12, B6, and riboflavin, all of which support cardiovascular function and energy metabolism. Vitamin B12 is abundant across most organ meats and is essential for red blood cell formation, neurological function, and energy metabolism.
Bovine heart contains significant amounts of iron, zinc, and selenium. Heme iron is especially high in certain organ meats, known for higher bioavailability compared to plant sources, supporting oxygen delivery in the body.
What sets heart apart is its collagen and elastin content. These structural proteins provide building blocks that support connective tissue health throughout the body, making it particularly valuable for formulations targeting joint health, skin elasticity, or recovery from physical stress.
Beef heart contains around 10β12 grams of fat per 100-gram serving. Beef heart has only 0.1 grams of net carbs per 100-gram serving. It is predominantly composed of protein and provides a complete amino acid profile consistent with other skeletal and cardiac muscle meats.
CoQ10 is an endogenous antioxidant produced in all cells that plays an essential role in energy metabolism and antioxidant protection. This natural antioxidant plays a major role in cellular metabolism since it contributes to oxidative phosphorylation by mediating electron transfer between Complexes I/II and Complex III in the mitochondrial inner membrane, but is also present in all cellular membranes and blood in both high-density lipoproteins (HDL) and LDL.
CoQ10 distribution is not uniform among different organs, and the highest concentration is observed in the heart, though its levels decrease with age. Advanced age is the major risk factor for cardiovascular disease and endothelial dysfunction triggered by oxidative stress that impairs mitochondrial bioenergetics and reduces NO bioavailability, thus affecting vasodilatation. The rationale for the use of CoQ10 in cardiovascular diseases is that the loss of contractile function due to an energy depletion status in the mitochondria and reduced levels of NO for vasodilatation has been associated with low endogenous CoQ10 levels.
Micronutrients such as CoQ10, L-carnitine, thiamine, amino acids including taurine, and other small molecules are defined as essential cofactors for energy transfer, biochemical maintenance, and physiological heart function. Deficiencies in CoQ10, L-carnitine, thiamine, and other B vitamins, and taurine are all well documented in the failing myocardium.
CoQ10 was first isolated from beef heart mitochondria: Crane, Hatefi, Lester, et al. isolated a quinone from beef heart mitochondria (Biochim Biophys Acta, 1957;25:220β221).
Taurine, an amino acid, holds promise for cardiovascular health through mechanisms such as calcium regulation, blood pressure reduction, and antioxidant and anti-inflammatory effects. It mitigates atherogenesis through several mechanisms, such as decreasing the activity of 3-hydroxy-3-methylglutaryl CoA reductase, increasing 7Ξ±-hydroxylase activity to expedite cholesterol degradation, and lowering reactive oxygen species.
Deficiencies of L-carnitine, thiamine, and taurine alone are well-established causes of cardiomyopathy.
Carnitine helps transport fatty acids into mitochondria for energy production. Taurine is particularly interesting because it is conditionally essential, meaning the body can produce it, but not always in sufficient quantities under stress.
Important methodological note: Despite confident marketing, there are no randomized controlled trials showing that freeze-dried bovine or porcine heart capsules improve cardiovascular health, endurance, or recovery in humans. A search of PubMed and major clinical trial registries finds no published studies specifically on desiccated heart supplements in humans. Claims about improved cardiovascular function or stamina are unsupported by peer-reviewed evidence.
Nutrient presence does not equal clinical benefit. While heart tissue contains CoQ10, L-carnitine, B12, and minerals, the doses in capsule servings are far below the amounts proven effective in studies. For example, clinical trials on CoQ10 for heart failure use 100β300 mg/day, while desiccated heart supplements may supply far less than 1% of that amount.
The scientific evidence reviewed below therefore pertains to the key isolated constituents of bovine heart β principally CoQ10 and taurine β as studied in purified supplement form, which constitutes the mechanistic and clinical basis for claims made about bovine heart.
CoQ10, or ubiquinone, is a lipid-soluble antioxidant essential for mitochondrial ATP production and cellular energy metabolism. Its therapeutic potential has been investigated in conditions marked by mitochondrial dysfunction, particularly chronic heart failure and statin-associated muscle symptoms. Robust evidence, including data from the Q-SYMBIO trial, demonstrates that CoQ10 supplementation can improve functional capacity, ejection fraction, and reduce major cardiovascular events in heart failure with reduced ejection fraction.
Q-SYMBIO Trial (randomized controlled trial): The Q-SYMBIO trial was a randomized, double-blind, placebo-controlled trial tracking 420 patients with moderate-to-severe heart failure for two years. Half received 300 mg CoQ10 daily (three 100 mg doses with meals); half received placebo. Both groups continued standard heart failure medications throughout the trial β ACE inhibitors, beta-blockers, and diuretics β meaning CoQ10 benefits were additive on top of established therapy. Over 2 years, the CoQ10 group showed a 43% reduction in major adverse cardiovascular events (hospitalization, cardiovascular death) and a 42% reduction in cardiovascular mortality β 18 deaths in the CoQ10 group vs 36 deaths in placebo over the 2-year period.
Numerous trials during the past 30 years examining CoQ10 in patients with heart failure have been limited by small numbers and lack of contemporary heart failure therapies. A substantial reduction of inflammatory and oxidative stress markers has been observed in several randomized clinical trials focused on cardiovascular diseases, even if more RCTs involving a larger number of patients will be necessary to strengthen these findings.
Recent research clearly showed the beneficial effect of CoQ10 supplementation in the treatment and prevention of cardiovascular disease in patients with heart failure in clinical trials. Findings record cardiovascular benefits for CoQ10 and antioxidative and anti-inflammatory properties for CoQH2 (ubiquinol); CoQ10 supplementation reduced cardiovascular death in patients with heart failure.
CoQ10 is generally safe, well-tolerated, and affordable, and emerging research supports its classification as a conditionally essential nutrient in heart failure.
Meta-analysis indicates that CoQ10 supplementation may be an effective adjunctive therapy for reducing systolic blood pressure, especially at doses below 200 mg/day and with longer treatment durations. However, its impact on diastolic blood pressure and heart rate appears minimal.
Clinical evidence shows that CoQ10 supplementation for prolonged periods is safe, well-tolerated, and significantly increases the concentration of CoQ10 in plasma up to 3β5 Β΅g/mL.
While robust evidence supports CoQ10 in heart failure with reduced ejection fraction, studies on its efficacy for statin myopathy have yielded inconsistent results, with some reporting symptom relief and others showing no significant benefit. Statin medications can reduce CoQ10 levels by inhibiting the same metabolic pathway used for both cholesterol and CoQ10 synthesis. The clinical relevance of this biochemical interaction remains an active area of investigation.
A meta-analysis of 20 randomized controlled trials included a pooled sample of 808 participants. Taurine demonstrated a significant reduction in heart rate (WMD = β3.579 bpm, 95% CI = β6.044 to β1.114, p = 0.004), systolic blood pressure (WMD = β3.999 mm Hg, 95% CI = β7.293 to β0.706, p = 0.017), diastolic blood pressure (WMD = β1.435 mm Hg, 95% CI = β2.484 to β0.386, p = 0.007), and a significant increase in left ventricular ejection fraction (WMD = 4.981%, 95% CI = 1.556 to 8.407, p = 0.004).
Despite these statistically significant pooled results, despite numerous clinical studies demonstrating the various health benefits of taurine, inconsistencies in outcomes present challenges in conclusively determining its effects on cardiovascular diseases.
Meta-analysis of RCTs highlights taurine supplementation's significant potential in mitigating key metabolic syndrome risk factors, including reductions in systolic blood pressure, diastolic blood pressure, fasting blood glucose, and triglyceride levels. This underscores its potential as a complementary therapeutic agent for metabolic syndrome management.
Taurine has been evidenced to reduce inflammatory biomarkers, such as C-reactive protein (CRP) and tumor necrosis factor alpha, while simultaneously enhancing fasting glucose and triglyceride levels, indicating significant cardiometabolic advantages.
The following characterizations reflect the state of evidence as of current literature:
A review in the Journal of the American College of Cardiology summarized the existing heart failure literature with respect to supplementation trials of key micronutrients involved in cardiac metabolism: coenzyme Q10, L-carnitine, thiamine, and amino acids including taurine. The following organ systems are implicated:
The heart has one of the highest energy demands of any organ in the body. As a muscle that contracts continuously without rest, the heart requires a constant supply of ATP to fuel its ceaseless pumping action. The concentration of CoQ10 in beef heart is extremely high to meet this incredible energy need. This mirrors the high CoQ10 demand of the human myocardium. The rationale for the use of CoQ10 in cardiovascular diseases is that the loss of contractile function due to energy depletion in the mitochondria and reduced levels of NO for vasodilatation has been associated with low endogenous CoQ10 levels.
CoQ10 is an organic molecule that was identified for the first time by Frederick Crane of Wisconsin (USA) in 1957. It is ubiquitously present in cell membranes and especially in the mitochondria in both reduced (ubiquinol) and oxidized (ubiquinone) forms. Endogenous CoQ10 production declines with age, and certain chronic conditions including heart failure and diabetes have been associated with lower CoQ10 levels.
Heme iron, especially high in certain organ meats, is known for higher bioavailability compared to plant sources, supporting oxygen delivery in the body. Bovine heart's heme iron content may contribute to red blood cell synthesis and management of iron-deficiency states, though direct clinical trials on bovine heart supplement use for iron status have not been identified.
Vitamin B12, for which beef heart is a best source, is well established in neurological function. Vitamin B12 is essential for red blood cell formation, neurological function, and energy metabolism.
Heart tissue's collagen and elastin content provides structural protein building blocks that support connective tissue health, making it potentially valuable for formulations targeting joint health, skin elasticity, or recovery from physical stress.
No clinical dosage guidelines have been established for bovine heart supplements as a category. The dosages below are reported as used in studies or observational contexts for specific isolated constituents derived from or associated with bovine heart.
For the specific supplement form (desiccated bovine heart capsules), no standardized or clinically validated dosage has been established in published peer-reviewed literature.
When sourced and processed carefully, beef organ supplements are considered safe for most healthy adults. In the United States, desiccated organ supplements are regulated as dietary supplements under DSHEA, not as drugs, meaning they do not require pre-market clinical proof of safety or efficacy.
Those with gout (a type of arthritis) should also watch their intake of organ meats. They contain purines (a naturally occurring compound), which worsens gout.
Organ meat is safe for most people to eat in moderation, but it is high in cholesterol and saturated fat, which can increase blood cholesterol level. If you have heart disease risk factors like high cholesterol, it is best to choose leaner muscle meat instead.
Certain organs, like liver and kidney, are dense in vitamins such as vitamin A and minerals like iron. In concentrated capsule form, daily use can push intake beyond safe levels, increasing the risk for hypervitaminosis A, iron overload, and related toxicity. The NIH Office of Dietary Supplements warns that chronic intake above 3,000 Β΅g/day of preformed vitamin A can cause liver damage, bone loss, and birth defects during pregnancy. Heart tissue itself is not as concentrated in vitamin A as liver, but this consideration applies when bovine heart supplements are sold as part of multi-organ blends.
Heavy metals can contaminate animal tissues through grazing behavior in cattle on contaminated soils, and through contaminated feed and water. Contamination with heavy metals is a serious threat because of their toxicity, bioaccumulation, and biomagnification in the food chain. These pollutants often have direct physiological toxic effects because they are stored or incorporated in tissues, sometimes permanently.
As filtration and detoxification organs, the liver and kidney can accumulate heavy metals (e.g., cadmium, lead) and environmental toxins. If the source animals are not pasture-raised and tested, these contaminants can end up in supplements. Heart is not a primary filtration organ, but the same risk applies if animals have been exposed to environmental contamination.
Freeze-dried organs retain most nutrients, but some vitamins and enzymes may degrade during processing. This can make supplements slightly less bioavailable compared to fresh, properly prepared organs.
Any consideration of CoQ10 supplementation should be discussed with a healthcare provider, particularly for individuals taking warfarin, antihypertensive medications, or those who are pregnant or breastfeeding. CoQ10 has structural similarity to vitamin K and may theoretically interfere with anticoagulant therapy, though the clinical magnitude of this interaction is uncertain.
Mad cow disease (bovine spongiform encephalopathy, BSE) spreads to people if they eat the brains or spinal cord of affected cattle. The likelihood of getting it from U.S. beef is extremely low. The brain and spinal cord of animals are generally not consumed, as they may carry a risk of transmitting certain diseases such as prion diseases like bovine spongiform encephalopathy or "mad cow disease." Heart tissue is not a high-risk tissue for prion disease under current BSE surveillance frameworks, but sourcing from inspected, regulated supply chains remains a standard precaution.
The FDA has issued warnings on desiccated glandular products containing unlisted hormones that pose health risks to consumers. This concern applies primarily to endocrine glands (adrenal, thyroid, pituitary) rather than to cardiac muscle, but it highlights the importance of product labeling transparency in the organ supplement category.
Health conditions that Bovine heart may help support.
Bovine heart is a source of both heme iron and vitamin B12, the two most critical nutrients for iron-deficiency and megaloblastic anemia. Heme iron bioavailability (25β30%) is substantially superior to non-heme iron. B12 from beef heart (~8.55 Β΅g/100 g) addresses B12-deficiency anemia.
CoQ10 β present at high concentration in bovine heart β is a potent endogenous antioxidant. A 2020 meta-analysis of 17 RCTs documented CoQ10 supplementation's ability to reduce membrane oxidative damage, enhance total antioxidant capacity, and activate antioxidant defense enzymes. Selenium, also concentrated in bovine heart, further supports glutathione peroxidase activity.
CoQ10 in bovine heart supports arterial health by restoring NO bioavailability, reducing LDL oxidation, and countering oxidative-stress-driven endothelial dysfunction, which underlies atherosclerosis. Clinical studies show CoQ10 supplementation attenuates markers of endothelial dysfunction and may slow cardiovascular disease progression.
Bovine heart provides L-carnitine and CoQ10, both of which have been studied for ergogenic effects. Clinical data show L-carnitine supplementation increases maximum oxygen consumption, power output, and exercise capacity; CoQ10 similarly shows performance-supporting effects in trials. These are constituent-based findings; no RCTs of bovine heart supplement specifically for athletic performance exist.
CoQ10, the primary bioactive constituent in bovine heart, has been assessed for blood pressure effects in multiple RCTs and meta-analyses. A 2025 meta-analysis of 45 RCTs found CoQ10 significantly reduced systolic BP (WMD β3.44 mmHg). Taurine, also present in bovine heart, has additional blood pressure-lowering evidence. Evidence is constituent-based.
Bovine heart concentrates three nutrients essential for cellular energy production: CoQ10 (electron transport chain), L-carnitine (mitochondrial fatty acid import), and B vitamins (cofactors in the TCA cycle and oxidative phosphorylation). Each is scientifically validated for its role in cellular ATP production.
CoQ10 and NADH both increase cellular ATP production through mitochondrial oxidative phosphorylation, and CoQ10 supplementation has been investigated in fatigue syndromes including ME/CFS. Reduced CoQ10 levels have been documented in chronic fatigue patients. Bovine heart is the richest food source of CoQ10 alongside contributing L-carnitine and B12.
CoQ10 and taurine in bovine heart have both been linked to endothelial function and circulation. CoQ10 supports NO bioavailability and vasodilation; reduced CoQ10 is associated with endothelial dysfunction. Taurine protects blood vessel integrity and cardiac contractility that drives circulation.
Bovine heart provides CoQ10, L-carnitine, and B vitamins β three nutrients with documented roles in cellular ATP production. CoQ10 is an essential electron carrier in oxidative phosphorylation; L-carnitine transports fatty acids into mitochondria for beta-oxidation; B12 supports erythrocyte and neurological function. Constituent-level clinical evidence is robust, though bovine heart capsule-specific trials are absent.
Bovine heart is the richest natural dietary source of CoQ10 (~11β13 mg/100 g), a coenzyme essential for cardiac energy metabolism. Clinical evidence for isolated CoQ10 at pharmacological doses (100β300 mg/day) shows improvements in heart failure outcomes, ejection fraction, and reductions in major cardiovascular events (Q-SYMBIO trial). Bovine heart also supplies taurine and L-carnitine, both of which have independent cardiovascular evidence. No RCTs exist specifically for bovine heart capsules; evidence is constituent-based.
Bovine heart provides taurine and CoQ10, both of which have documented roles in cardiac electrophysiology. Taurine modulates calcium handling and membrane excitability in cardiomyocytes; CoQ10 has been investigated as an adjuvant in atrial fibrillation. Evidence comes from constituent-level studies, not bovine heart capsule trials.
CoQ10, the dominant bioactive in bovine heart, is an essential and well-characterized mitochondrial electron carrier required for oxidative phosphorylation. Clinical evidence shows CoQ10 deficiency impairs mitochondrial function, and supplementation restores it. L-carnitine in bovine heart also plays a direct mitochondrial role via fatty acid import.
L-carnitine found in bovine heart has been specifically studied for post-exercise muscle recovery. A meta-analysis of 7 RCTs found L-carnitine significantly reduced muscle soreness at 0, 24, 48, 72, and 96 hours post-exercise vs. placebo. Bovine heart also provides complete protein and taurine relevant to muscle repair.
Bovine heart provides vitamin B12 in high concentration (~8.55 Β΅g/100 g), essential for myelin sheath integrity, neurotransmitter synthesis, and neuronal function. Deficiency of B12 causes peripheral neuropathy and neurological decline. CoQ10 has also been investigated as a neuroprotective agent.
Bovine heart provides L-carnitine, CoQ10, taurine, and heme iron β four nutrients linked to physical endurance via distinct mechanisms including mitochondrial fat oxidation, ATP production, anti-fatigue effects, and oxygen delivery. Clinical trials of the constituent nutrients at pharmacological doses show performance and endurance benefits.
Body systems that Bovine heart may help support.
Go back